Showing results (61-70 of 134) with videos related to
Sort By:
Pageof 14
Journal of the National Cancer Institute|February 8, 2022
Identification of Mitochondrial DNA Variants Associated With Risk of NeuroblastomaXiao Chang, Yichuan Liu, Joseph Glessner, et al.Bioinformatics (Oxford, England)|February 11, 2025
ImmunoTar-integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.Genome Research|August 11, 2006
STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experimentsSharon J Diskin, Thomas Eck, Joel Greshock, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
Advancing childhood cancer research through young investigator and advocate collaborationAmber K Weiner, Antonia Palmer, Melanie Frost Moll, et al.Genes, Chromosomes & Cancer|July 25, 2007
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expressionYael P Mosse, Sharon J Diskin, Nora Wasserman, et al.Molecular Cancer Therapeutics|November 7, 2025
Defining the functional role and potential as an immunotherapeutic target of ALCAM in neuroblastomaJarrett Lindsay, Jonathan Gaither, David Groff, et al.Nephron|January 1, 1984
Thallium-201 myocardial imaging in patients on chronic hemodialysisC M Gelber, C J Diskin, B C Claunch, et al.Journal of the National Cancer Institute|March 18, 2014
Rare variants in TP53 and susceptibility to neuroblastomaSharon J Diskin, Mario Capasso, Maura Diamond, et al.Journal of the National Cancer Institute|December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survivalEric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.Carcinogenesis|December 11, 2012
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibilityMario Capasso, Sharon J Diskin, Francesca Totaro, et al.Pageof 14